Evidence map›Paper›PMID 31170415›Full record

ArticleToxicology and applied pharmacology2019

Arsenic-induced metabolic shift triggered by the loss of miR-199a-5p through Sp1-dependent DNA methylation.

Jun He, Weitao Liu, Xin Ge, Gao-Chan Wang, Vilas Desai, Shaomin Wang, Wei Mu, Vikas Bhardwaj, Erin Seifert, Ling-Zhi Liu and 3 more

Open access · greenAbstract read
In one paragraph

Article in Toxicology and applied pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Specificity Proteins (Sp) and Cancer.International journal of molecular sciences · 2023
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Jun HeDepartment of Pathology, Anatomy & Cell Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, United States of America. Electronic address: Jun.he@jefferson.edu.
Weitao LiuDepartment of Pathology, Nanjing Medical University, Nanjing, China.
Xin GeDepartment of Pathology, Nanjing Medical University, Nanjing, China.
Gao-Chan WangDepartment of Pathology, Anatomy & Cell Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, United States of America.
Vilas DesaiDepartment of Pharmaceutical Sciences, College of Pharmacy, Thomas Jefferson University, Philadelphia, PA 19107, United States of America.
Shaomin WangDepartment of Pathology, Anatomy & Cell Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, United States of America.
Wei MuSchool of Public Health, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Vikas BhardwajDepartment of Pharmaceutical Sciences, College of Pharmacy, Thomas Jefferson University, Philadelphia, PA 19107, United States of America.
Erin SeifertDepartment of Pathology, Anatomy & Cell Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, United States of America.
Ling-Zhi LiuDepartment of Pathology, Carver College of Medicine, University of Iowa, Iowa City, IW 52242, United States of America.
Alok BhushanDepartment of Pharmaceutical Sciences, College of Pharmacy, Thomas Jefferson University, Philadelphia, PA 19107, United States of America.
Stephen C PeiperDepartment of Pathology, Anatomy & Cell Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, United States of America.
Bing-Hua JiangDepartment of Pathology, Carver College of Medicine, University of Iowa, Iowa City, IW 52242, United States of America. Electronic address: bing-hua-jiang@uiowa.edu.
Thomas Jefferson University · USNanjing Medical University · CNUniversity of Iowa · USShanghai Jiao Tong University · CN

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Douglas Robert Spitz · 2000 to 2026
$70.0M
Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Brandi Janssen · 1990 to 2026
$40.5M
Mechanism of lung cancer resistance to tyrosine kinase inhibitor and radiation treatmentsR01CA232587 · NCI · UNIVERSITY OF IOWA · PI SIMONE, NICOLE L · 2018 to 2022
$2.9M
Molecular Mechanism of Arsenic CarcinogenesisR01ES020868 · NIEHS · UNIVERSITY OF IOWA · PI JIANG, BINGHUA · 2014 to 2018
$1.7M
NOX4 Mediates Oxidative Stress in Ovarian Tumor growth and treatment ResponseR01CA193511 · NCI · UNIVERSITY OF IOWA · PI HE, JUN · 2016 to 2020
$1.7M
Chromium in carcinogenesis and angiogenesisR01ES027901 · NIEHS · UNIVERSITY OF IOWA · PI HE, JUN · 2018 to 2022
$1.6M
New mechanisms of acquired resistance to EGFR-TKIs in Non-small-cell lung cancerR00CA215316 · NCI · THOMAS JEFFERSON UNIVERSITY · PI HE, JUN · 2020 to 2022
$747k
New Mechanism of Arsenic CarcinogenesisK02ES029119 · NIEHS · UNIVERSITY OF IOWA · PI LIU, LING-ZHI · 2018 to 2022
$613k
New mechanisms of acquired resistance to EGFR-TKIs in Non-small-cell lung cancerK99CA215316 · NCI · THOMAS JEFFERSON UNIVERSITY · PI HE, JUN · 2018 to 2019
$196k
NCI NIH HHS K99 CA215316NCI NIH HHS R00 CA215316NCI NIH HHS R01 CA193511NCI NIH HHS R01 CA232587NIEHS NIH HHS K02 ES029119NIEHS NIH HHS P30 ES005605NIEHS NIH HHS R01 ES020868NIEHS NIH HHS R01 ES027901
6 · The paper itself

Abstract

Inorganic arsenic is an environmental carcinogen that poses a major global public health risk. A high percentage of drinking water from wells in the U.S. contains higher-than-normal levels of arsenic, suggesting an increased risk of arsenic-induced deleterious effects. In addition to primary preventive measures, therapeutic strategies need to effectively address and integrate multiple molecular mechanisms underlying arsenic-induced carcinogenesis. We previously showed that the loss of miR-199a-5p in arsenic-transformed cells is pivotal to promote arsenic-induced angiogenesis and tumor growth in lung epithelial cells. In this study, we further showed that subacute or chronic exposure to arsenic diminished miR-199a-5p levels largely due to DNA methylation, which was achieved by increased DNA methyltransferase-1 (DNMT1) activity, mediated by the formation of specific protein 1 (Sp1)/DNMT1 complex. In addition to the DNA hypermethylation, arsenic exposure also repressed miR-199a transcription through a transcriptional repressor Sp1. We further identified an association between miR-199a-5p repression and the arsenic-mediated energy metabolic shift, as reflected by mitochondria defects and a switch to glycolysis, in which a glycolytic enzyme pyruvate kinase 2 (PKM2) was a functional target of miR-199a-5p. Taken together, the repression of miR-199a-5p through both Sp1-dependent DNA methylation and Sp1 transcriptional repression promotes an arsenic-mediated metabolic shift from mitochondria respiration to aerobic glycolysis via PKM2.

Indexed as

Activation, MetabolicArsenicCarcinogenesisCell LineDNA MethylationGlycolysisHumansMicroRNAsSp1 Transcription FactorArsenicMicroRNAsmirn199 microRNA, humanSP1 protein, humanSp1 Transcription FactorArsenicDNA methylationGlycolysismiR-199a-5pPKM2Sp1

Identifiers

PMID31170415
PMCPMC6788774
OpenAlexW2948733244

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.